Scientists at Cornell University may be closing in on the long-sought “holy grail” of male contraception: a safe, reversible, nonhormonal method that completely halts sperm production. In a breakthrough mouse study, researchers used a compound called JQ1 to temporarily shut down meiosis—the critical process that produces sperm—without causing lasting harm. After treatment stopped, sperm production bounced back, fertility returned, and the animals produced healthy offspring.
    • squaresinger@lemmy.worldEnglish
      0·
      17 days ago

      Yeah, I’d say having a study participant trying to commit suicide because of the birth control is kinda severe.

      But also look at who cancelled the study. Was it the participants? Was it the potential customers? Or was it a company that was afraid of lawsuits?

      I don’t like you trying to blame “the men” because some suits pulled the plug because they feared losing money.

      The thing with the vasalgel/RISUG thing is that there aren’t any reported side effects and it still was cancelled.

      If you look at actual research, there’s actually quite a demand for novel male contraception methods:

      The proportion of male participants in clinical trials reporting willingness to use a male contraceptive ranged from 34% to 82% and the proportion from surveys about hypothetical methods ranged from 14% to 83% [2]. Specific to the United States (US), a population survey conducted in 2002 of 1500 men reported willingness among 49.3% of respondents [6]; two decades later, an online survey of 2066 men from the US and Canada reported willingness among 75% of respondents

      https://www.sciencedirect.com/science/article/pii/S001078242400101X